Dextroamphetamine sulfate 5 MG Oral Tablet — RxCUI 884386
RxNorm drug concept · Semantic clinical drug
RxCUI 884386
Semantic clinical drug · SCD
● Current RxNorm concept 36 FDA products
56 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI884386
Official nameDextroamphetamine sulfate 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped36
Package NDCs mapped56
Reported Medicaid activity (SDUD)67,813 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextroamphetamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats ADHD, and some oral forms are also used for narcolepsy. Which use and age range applies depends on the product you have. Your prescriber decides if it fits you or your ch...
- Take it exactly as prescribed, usually at the lowest dose that works. Avoid late-evening doses because they can keep you awake. If you use the Xelstrym patch, put it on about 2 hou...
- Common ones are reduced appetite, trouble sleeping, headache, stomach upset and irritability. Kids may lose weight, so we watch growth. Call your doctor for chest pain, a racing he...
- Check with me first. MAO inhibitors are a serious problem, and antidepressants, triptans, tramadol and St. John’s Wort can raise the risk of serotonin syndrome. Vitamin C and fruit...
🕸️ Concept Web — How Dextroamphetamine sulfate 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dextroamphetamine sulfate 5 MG Oral Tablet
RxCUI 884386 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Dextroamphetamine
3288IN -
Dextroamphetamine sulfate
3287PIN
-
Dextroamphetamine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zenzedi
1425332BN
-
Zenzedi
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextroamphetamine Oral Tablet
371753SCDF -
Dextroamphetamine sulfate Oral Tablet
2647496SCDFP -
Dextroamphetamine Oral Product
1154565SCDG -
Dextroamphetamine Pill
1154566SCDG -
Dextroamphetamine sulfate Oral Product
2662479SCDGP -
Dextroamphetamine sulfate Pill
2661847SCDGP -
Dextroamphetamine Oral Tablet [Zenzedi]
1425334SBDF -
Dextroamphetamine sulfate Oral Tablet [Zenzedi]
2656743SBDFP - +5 more in this family
-
Dextroamphetamine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextroamphetamine sulfate 5 MG
578398SCDC -
Dextroamphetamine sulfate 5 MG Oral Tablet [Zenzedi]
1425339SBD -
Dextroamphetamine sulfate 5 MG [Zenzedi]
1425338SBDC
-
Dextroamphetamine sulfate 5 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dextroamphetamine sulfate 5 MG
SCDC · 578398 -
Dextroamphetamine Oral Tablet
SCDF · 371753 -
Dextroamphetamine sulfate Oral Tablet
SCDFP · 2647496 -
Dextroamphetamine Oral Product
SCDG · 1154565 -
Dextroamphetamine Pill
SCDG · 1154566 -
Dextroamphetamine sulfate Oral Product
SCDGP · 2662479 -
Dextroamphetamine sulfate Pill
SCDGP · 2661847
Brand-Name Concepts
-
Dextroamphetamine sulfate 5 MG Oral Tablet [Zenzedi]
SBD · 1425339 -
Dextroamphetamine sulfate 5 MG [Zenzedi]
SBDC · 1425338 -
Dextroamphetamine Oral Tablet [Zenzedi]
SBDF · 1425334 -
Dextroamphetamine sulfate Oral Tablet [Zenzedi]
SBDFP · 2656743 -
Zenzedi Oral Product
SBDG · 1425335 -
Zenzedi Pill
SBDG · 1425336 -
Zenzedi
BN · 1425332
📦 FDA Products & Package NDCs
36 products · 56 package NDCs
56 package NDCs map to RxCUI 884386 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00406-8958-01 | 100 TABLET in 1 BOTTLE (0406-8958-01) | DEXTROAMPHETAMINE SULFATE | SpecGx LLC | 2002-01-29 |
| 00406-8959-01 | 100 TABLET in 1 BOTTLE (0406-8959-01) | DEXTROAMPHETAMINE SULFATE | SpecGx LLC | 2002-01-29 |
| 00555-0952-02 | 100 TABLET in 1 BOTTLE (0555-0952-02) | Dextroamphetamine Sulfate | Teva Pharmaceuticals USA, Inc. | 2001-02-12 |
| 00555-0953-02 | 100 TABLET in 1 BOTTLE (0555-0953-02) | Dextroamphetamine Sulfate | Teva Pharmaceuticals USA, Inc. | 2001-02-12 |
| 10702-0065-01 | 100 TABLET in 1 BOTTLE (10702-065-01) | Dextroamphetamine Sulfate | KVK-Tech, Inc. | 2015-11-23 |
| 10702-0065-03 | 30 TABLET in 1 BOTTLE (10702-065-03) | Dextroamphetamine Sulfate | KVK-Tech, Inc. | 2015-11-23 |
| 10702-0065-06 | 60 TABLET in 1 BOTTLE (10702-065-06) | Dextroamphetamine Sulfate | KVK-Tech, Inc. | 2015-11-23 |
| 10702-0066-01 | 100 TABLET in 1 BOTTLE (10702-066-01) | Dextroamphetamine Sulfate | KVK-Tech, Inc. | 2015-11-23 |
| 10702-0066-03 | 30 TABLET in 1 BOTTLE (10702-066-03) | Dextroamphetamine Sulfate | KVK-Tech, Inc. | 2015-11-23 |
| 10702-0066-06 | 60 TABLET in 1 BOTTLE (10702-066-06) | Dextroamphetamine Sulfate | KVK-Tech, Inc. | 2015-11-23 |
| 11534-0188-01 | 100 TABLET in 1 BOTTLE (11534-188-01) | DEXTROAMPHETAMINE SULFATE | SUNRISE PHARMACEUTICAL, INC. | 2018-07-04 |
| 11534-0188-03 | 1000 TABLET in 1 BOTTLE (11534-188-03) | DEXTROAMPHETAMINE SULFATE | SUNRISE PHARMACEUTICAL, INC. | 2018-07-04 |
| 11534-0189-01 | 100 TABLET in 1 BOTTLE (11534-189-01) | DEXTROAMPHETAMINE SULFATE | SUNRISE PHARMACEUTICAL, INC. | 2018-07-04 |
| 11534-0189-03 | 1000 TABLET in 1 BOTTLE (11534-189-03) | DEXTROAMPHETAMINE SULFATE | SUNRISE PHARMACEUTICAL, INC. | 2018-07-04 |
| 13107-0035-01 | 100 TABLET in 1 BOTTLE (13107-035-01) | DEXTROAMPHETAMINE SULFATE | Aurolife Pharma, LLC | 2013-07-31 |
| 13107-0035-50 | 50 TABLET in 1 BOTTLE (13107-035-50) | DEXTROAMPHETAMINE SULFATE | Aurolife Pharma, LLC | 2013-07-31 |
| 13107-0035-99 | 1000 TABLET in 1 BOTTLE (13107-035-99) | DEXTROAMPHETAMINE SULFATE | Aurolife Pharma, LLC | 2013-07-31 |
| 13107-0036-01 | 100 TABLET in 1 BOTTLE (13107-036-01) | DEXTROAMPHETAMINE SULFATE | Aurolife Pharma, LLC | 2013-07-31 |
| 13107-0036-50 | 50 TABLET in 1 BOTTLE (13107-036-50) | DEXTROAMPHETAMINE SULFATE | Aurolife Pharma, LLC | 2013-07-31 |
| 13107-0036-99 | 1000 TABLET in 1 BOTTLE (13107-036-99) | DEXTROAMPHETAMINE SULFATE | Aurolife Pharma, LLC | 2013-07-31 |
| 24338-0850-03 | 30 TABLET in 1 BOTTLE (24338-850-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-10 |
| 24338-0851-03 | 30 TABLET in 1 BOTTLE (24338-851-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 24338-0852-03 | 30 TABLET in 1 BOTTLE (24338-852-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 24338-0853-03 | 30 TABLET in 1 BOTTLE (24338-853-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 24338-0854-03 | 30 TABLET in 1 BOTTLE (24338-854-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 24338-0855-03 | 30 TABLET in 1 BOTTLE (24338-855-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 24338-0856-03 | 30 TABLET in 1 BOTTLE (24338-856-03) | Zenzedi | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 27808-0089-01 | 100 TABLET in 1 BOTTLE, PLASTIC (27808-089-01) | Dextroamphetamine Sulfate | Cranbury Pharmaceuticals, LLC | 2023-02-28 |
| 27808-0090-01 | 100 TABLET in 1 BOTTLE, PLASTIC (27808-090-01) | Dextroamphetamine Sulfate | Cranbury Pharmaceuticals, LLC | 2023-02-28 |
| 43386-0870-01 | 100 TABLET in 1 BOTTLE (43386-870-01) | Dextroamphetamine Sulfate | Lupin Pharmaceuticals,Inc. | 2016-04-25 |
| 43386-0871-01 | 100 TABLET in 1 BOTTLE (43386-871-01) | Dextroamphetamine Sulfate | Lupin Pharmaceuticals,Inc. | 2016-04-25 |
| 52536-0500-01 | 100 TABLET in 1 BOTTLE (52536-500-01) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2012-07-16 |
| 52536-0500-03 | 30 TABLET in 1 BOTTLE (52536-500-03) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-04-14 |
| 52536-0510-01 | 100 TABLET in 1 BOTTLE (52536-510-01) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2012-07-20 |
| 52536-0510-03 | 30 TABLET in 1 BOTTLE (52536-510-03) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-04-14 |
| 52536-0515-03 | 30 TABLET in 1 BOTTLE (52536-515-03) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-08-06 |
| 52536-0520-03 | 30 TABLET in 1 BOTTLE (52536-520-03) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-08-06 |
| 52536-0530-03 | 30 TABLET in 1 BOTTLE (52536-530-03) | Dextroamphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-08-06 |
| 63629-2375-01 | 100 TABLET in 1 BOTTLE (63629-2375-1) | DEXTROAMPHETAMINE SULFATE | Bryant Ranch Prepack | 2018-07-04 |
| 72162-1233-01 | 100 TABLET in 1 BOTTLE (72162-1233-1) | DEXTROAMPHETAMINE SULFATE | Bryant Ranch Prepack | 2024-09-06 |
| 72162-1233-03 | 30 TABLET in 1 BOTTLE (72162-1233-3) | DEXTROAMPHETAMINE SULFATE | Bryant Ranch Prepack | 2024-09-06 |
| 72162-2349-03 | 30 TABLET in 1 BOTTLE (72162-2349-3) | Dextroamphetamine Sulfate | Bryant Ranch Prepack | 2021-04-14 |
| 75826-0120-10 | 100 TABLET in 1 BOTTLE, PLASTIC (75826-120-10) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0120-30 | 30 TABLET in 1 BOTTLE, PLASTIC (75826-120-30) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0121-10 | 100 TABLET in 1 BOTTLE, PLASTIC (75826-121-10) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0121-30 | 30 TABLET in 1 BOTTLE, PLASTIC (75826-121-30) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0122-10 | 100 TABLET in 1 BOTTLE, PLASTIC (75826-122-10) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0122-30 | 30 TABLET in 1 BOTTLE, PLASTIC (75826-122-30) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0123-10 | 100 TABLET in 1 BOTTLE, PLASTIC (75826-123-10) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
| 75826-0123-30 | 30 TABLET in 1 BOTTLE, PLASTIC (75826-123-30) | Dextroamphetamine Sulfate | Winder Laboratories LLC | 2023-03-24 |
Observed labelers:
Winder Laboratories LLC (14) ·
Azurity Pharmaceuticals, Inc. (7) ·
Wilshire Pharmaceuticals, Inc. (7) ·
Aurolife Pharma, LLC (6) ·
KVK-Tech, Inc. (6) ·
Bryant Ranch Prepack (4)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.